About Us

Our Facilities

A clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancer and stem cell therapies for degenerative diseases


Our Facilities

CBMG currently operates GMP facilities in Shanghai and Wuxi, China that meet international standards and have been certified by China Food and Drug Administration (CFDA) authorized accreditation agencies.

Current total GMP space is 70,000 sq ft, with ample production capacity to support simultaneous clinical trials for cell therapy products.

CBMG has a manufacturing and technology team with more than 30 years of relevant experience in China, England, and the USA